BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 29350397)

  • 1. The burden of non-melanoma skin cancers in Auckland, New Zealand.
    Pondicherry A; Martin R; Meredith I; Rolfe J; Emanuel P; Elwood M
    Australas J Dermatol; 2018 Aug; 59(3):210-213. PubMed ID: 29350397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing incidence of non-melanoma skin cancer in New Zealand.
    Brougham ND; Dennett ER; Tan ST
    ANZ J Surg; 2011 Sep; 81(9):633-6. PubMed ID: 22295395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
    Hayes RC; Leonfellner S; Pilgrim W; Liu J; Keeling DN
    J Cutan Med Surg; 2007; 11(2):45-52. PubMed ID: 17374314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prevalence of non-melanoma skin cancer in Australia: A systematic review.
    Perera E; Gnaneswaran N; Staines C; Win AK; Sinclair R
    Australas J Dermatol; 2015 Nov; 56(4):258-67. PubMed ID: 25716064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995.
    Plesko I; Severi G; Obsitníková A; Boyle P
    Neoplasma; 2000; 47(3):137-42. PubMed ID: 11043834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence and multiplicity rates of keratinocyte cancers in Australia.
    Pandeya N; Olsen CM; Whiteman DC
    Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985.
    Staples MP; Elwood M; Burton RC; Williams JL; Marks R; Giles GG
    Med J Aust; 2006 Jan; 184(1):6-10. PubMed ID: 16398622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
    Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
    Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?
    Staples M; Marks R; Giles G
    Int J Cancer; 1998 Oct; 78(2):144-8. PubMed ID: 9754642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: A population-based study.
    Rubió-Casadevall J; Hernandez-Pujol AM; Ferreira-Santos MC; Morey-Esteve G; Vilardell L; Osca-Gelis G; Vilar-Coromina N; Marcos-Gragera R
    Cancer Epidemiol; 2016 Dec; 45():6-10. PubMed ID: 27639035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance.
    Kaldor J; Shugg D; Young B; Dwyer T; Wang YG
    Int J Cancer; 1993 Apr; 53(6):886-91. PubMed ID: 8473047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019.
    Zhang W; Zeng W; Jiang A; He Z; Shen X; Dong X; Feng J; Lu H
    Cancer Med; 2021 Jul; 10(14):4905-4922. PubMed ID: 34105887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin cancer by state and territory.
    Pollack A; McGrath M; Henderson J; Britt H
    Aust Fam Physician; 2014 Aug; 43(8):507. PubMed ID: 25114982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention.
    Deady S; Sharp L; Comber H
    Br J Dermatol; 2014 Aug; 171(2):324-31. PubMed ID: 24666396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of basal and squamous cell carcinoma in Belgium: the need for a uniform and compulsory registration.
    Callens J; Van Eycken L; Henau K; Garmyn M
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):1912-1918. PubMed ID: 27256411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010.
    Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S
    J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006-11.
    Sella T; Goren I; Shalev V; Shapira H; Zandbank J; Rosenblum J; Kimlin MG; Chodick G
    Br J Dermatol; 2015 Jan; 172(1):202-7. PubMed ID: 24976239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.